Anthropic Launches Claude Science as Standalone Flagship for Life Sciences

Anthropic announced Claude Science at a closed event for pharmaceutical executives and biotech researchers. The system executes high-level research instructions using integrated tools for scientific databases and cluster compute. It extends prior Claude for Life Sciences plugins into a full standalone model. The company stated it will apply the product internally to rare disease drug programs.

Harvard physicist Matthew Schwartz documented Opus 4.5 performance at second-year graduate student level on independent projects. John Jumper's move from DeepMind to Anthropic supplies direct AlphaFold lineage expertise. Reproducibility features trace every output to source code and data runs, addressing a documented failure mode in agent-driven science workflows.

DeepMind's post-AlphaFold output has narrowed to meteorology and materials while coding benchmarks show Anthropic models leading deployment records. Claude Science targets the same scientist users already routing code through Claude Code but adds cluster orchestration absent in general agents. This specialization pattern matches observed 2025 agent gains where narrow tooling outperformed general models on domain tasks.

Operational rollout begins with paid Claude subscribers. Expect measurable productivity deltas in labs that already delegate code but lack cluster management expertise. Next benchmark cycle will test whether Claude Science exceeds the 2025 agent threshold on end-to-end wet-lab design cycles.